Yasunari Niimi

Yasunari Niimi

Auto-generated profile, based on publicly available information

Yasunari Niimi

Department of Neuroendovascular Therapy, St Luke’s International Hospital, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1997 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
YNYasunari Niimi
Yasunari Niimi
ABAlex Berenstein
Alex Berenstein
ASAvi Setton
Avi Setton
ANAndreas Neophytides
Andreas Neophytides
OBJECTIVE. To evaluate the efficacy of embolization for spinal dural arteriovenous fistulae (SDAVF).METHODS:. We reviewed 49 cases of SDAVF treated by

1 September 2005 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
TJThottala Jayaraman
Thottala Jayaraman
VBVanessa Berenstein
Vanessa Berenstein
XLXiaguai Li
Xiaguai Li
JMJillian Mayer
Jillian Mayer
MSMichael Silane
Michael Silane
ABAlejandro Berenstein
Alejandro Berenstein
OBJECTIVE:. Although intracranial aneurysms (IAs) are a major public health problem in the United States, few etiological factors are known. Most aneury

1 November 2005 in Neurosurgery
Verified
Journal Article
Closed access
HSHadas Stiebel-Kalish
Hadas Stiebel-Kalish
YKYuval Kalish
Yuval Kalish
RBRuth Huna Bar-On
Ruth Huna Bar-On
ASAvi Setton
Avi Setton
YNYasu Niimi
Yasu Niimi
MKMark J. Kupersmith
Mark J. Kupersmith
OBJECTIVE: We present the largest reported cohort of carotid cavernous aneurysms (CCA), comparing the neuro-ophthalmic presentation, complications, and outcome with and without endovascular treatment. METHODS: Retrospective review of 185 patients with 206 CCAs examined between 1980 and 2001 at a tertiary neuro-ophthalmology and neurovascular service. Patients' symptoms and findings at presentation were recorded and compared with those at outcome. The effect of treatment on outcome and on complication rate was analyzed using the χ2 test, multivariate analysis of covariance, model-selection log-linear analysis, and multinomial logistic regression. RESULTS: Long-term follow-up was available for 189 of 206 CCAs. Seventy-four CCAs underwent treatment (endovascular, 67 [91%]; surgical treatment, 6 [9%]), and 115 were followed for an average of 4 years, two of which required later treatment. Treatment reduced the incidence and severity of pain, even after adjusting for the severity of initial pain (F(1,192 = 9.59, P = 0.002). Treatment did not significantly affect the patient's final diplopia after adjusting for their initial diplopia (F(1, 182 = 2.01, P = 0.158). Statistical examination revealed that the treated group had a higher proportion of neurological and visual complications than people who were not treated (2(2). = 25.26, P = 0.0003). CONCLUSION: Endovascular treatment of carotid cavernous aneurysms leads to a significantly higher rate of pain resolution compared with untreated patients, even after adjusting for initial pain severity. Diplopia may not resolve after treatment. The results of this study underscore our approach indicating treatment only in cases of debilitating pain, visual loss from compression, or diplopia in primary gaze or in patients with risk factors for major complications such as pre-existing coagulopathy or sphenoid sinus erosion.

1 May 2012 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
ABAlex Berenstein
Alex Berenstein
JFJohanna T. Fifi
Johanna T. Fifi
YNYasunari Niimi
Yasunari Niimi
SPSalvatore Presti
Salvatore Presti
RORafael Ortiz
Rafael Ortiz
WMWalter Molofsky
Walter Molofsky
BACKGROUND:. Untreated patients with symptomatic neonatal presentation of vein of Galen aneurismal malformations (VGAMs) carry almost 100% morbidity an

1 April 2006 in Stroke
Verified
Journal Article
Closed access
YNYasunari Niimi
Yasunari Niimi
JSJoon Song
Joon Song
MMMary Madrid
Mary Madrid
ABAlejandro Berenstein
Alejandro Berenstein
Background and Purpose— The authors report their experience using Matrix coils in the treatment of cerebral aneurysms. Methods— The outcomes of 72 consecutive patients (76 aneurysms) who underwent coiling using Matrix coils at our institution were retrospectively analyzed. Results— Seventy-four aneurysms in 70 patients were coiled using Matrix coils (ranging 3% to 100% by coil length; mean 68.8%). Two patients underwent regular platinum coil embolization after failed Matrix coil placement. Thirty-two (42%) ruptured aneurysms were acutely treated. In 46 aneurysms, Matrix composed >50% of coil length. Complete aneurysm occlusion was obtained in 13 aneurysms (17.6%), neck remnant in 30 (40.5%), and dome filling in 31 (41.9%). Procedural morbidity and mortality rates were 1.4% and 1.4%, respectively. Angiographic follow-up was obtained in 63.5% (47 of 74 aneurysms; average 12.2 months; range 0 to 34). In these 47 angiographically followed aneurysms, the overall recanalization rate was 57.4%. In aneurysms with >50% Matrix coils, 76.1% had angiographic follow-up (35 of 46), and in this group, the overall recanalization rate was 54.3% (19 of 35): 25% (1 of 4) for very small (<5 mm); 33% (4 of 12) for small-size (<10 mm)/small-neck (<4 mm); and 63% (5 of 8) for small-size/wide-neck (≥4 mm). A total of 82% (9 of 11) recanalization occurred in large aneurysms (≥10 to 25 mm). Ten aneurysms (21.3%; 10 of 47) underwent retreatment. Clinical follow-up was obtained in 61 (86%) patients (average 15 months; range 1 to 37): 87% of patients were Glasgow Outcome Scale 4 or 5. Conclusion— The use of Matrix coils resulted in worse recanalization rates than that reported for Guglielmi detachable bare platinum coils.

1 June 2007 in Journal of Neurosurgery
Verified
Journal Article
Closed access
NHNavraj S. Heran
Navraj S. Heran
JSJoon K. Song
Joon K. Song
MKMark J. Kupersmith
Mark J. Kupersmith
YNYasunari Niimi
Yasunari Niimi
KNKatsunari Namba
Katsunari Namba
ABAlejandro Berenstein
Alejandro Berenstein
Object: The optimal therapy for ophthalmic segment aneurysms with anterior optic pathway compression (AOPC) is undecided. Surgical results have been described, but the results of endovascular coil therapy have not been well documented. Methods: The authors retrospectively reviewed data obtained in all patients who harbored unruptured ophthalmic segment aneurysms with AOPC who underwent endovascular coil therapy at their institution. They analyzed baseline and outcome visual function, aneurysm features, extent of aneurysm closure, internal carotid artery (ICA) occlusion, additional interventions, and neurological outcome. In 17 patients (16 women), age 38 to 83 years, there were 28 affected eyes. All aneurysms were greater than 10 mm in diameter. In the initial procedures 16 of 17 patients received endosaccular coils and the ICA was preserved; in one patient the aneurysm was trapped and the ICA occluded. Patients then underwent follow up for a mean of 2.90 years (range 1 month–11.2 years) after the last procedure. One patient died of subarachnoid hemorrhage (SAH) 1 month postoperatively and thus no follow-up data were available for this case. Vision worsened in six patients, stabilized in four, and improved in six. Twelve patients underwent 13 subsequent procedures, including endovascular ICA occlusion in seven, repeated coil therapy in five, and optic nerve decompression in one; vision improved in 83% of these cases after ICA occlusion. A second patient died of SAH 5 months after repeated coil treatment. At the final follow up, vision had improved in eight patients (50%), stabilized in four (25%), and worsened in four (25%). In 16 patients with follow-up studies, aneurysm closure was complete in eight (50%) and incomplete in eight (50%). Conclusions: The authors found that in patients with ophthalmic segment aneurysms causing chronic AOPC, endosaccular platinum coil therapy, with ICA preservation, may not benefit vision and that additional procedures may be needed. Evaluation of their results suggests that endovascular trapping of the aneurysm and sacrifice of the ICA appear to result in good visual, clinical, and anatomical outcomes.